Peter Black, MD, FACS, FRCSC, presented “Clinical Implications of Similarities and Differences Between Upper-Tract and Bladder Urothelial Carcinoma” for the Grand Rounds in Urology audience in November, 2019.
How to cite: Black, Peter. “Clinical Implications of Similarities and Differences Between Upper-Tract and Bladder Urothelial Carcinoma” November, 2019. Accessed Nov 2024. https://grandroundsinurology.com/clinical-implications-of-similarities-and-differences-between-upper-tract-and-bladder-urothelial-carcinoma/
Clinical Implications of Similarities and Differences Between Upper-Tract and Bladder Urothelial Carcinoma – Summary:
Peter Black, MD, FACS, FRCSC, a Urologic Oncologist at Vancouver General Hospital, a Senior Research Scientist at the Vancouver Prostate Centre, and a Professor in the Department of Urologic Sciences at the University of British Columbia, examines key differences between upper-tract and bladder urothelial carcinomas, and their impact on diagnosis and treatment of each respective disease. He discusses subtle molecular differences between each disease, how these variations’ relationship to genetic alterations could lead to marker-based therapy, as well as treatments that are effective in treating both diseases.
ABOUT THE AUTHOR
Dr. Peter Black is a urologic oncologist at Vancouver General Hospital, a research scientist at the Vancouver Prostate Centre, and a Professor in the Department of Urologic Sciences at the University of British Columbia (UBC). He received his undergraduate degree from UBC and his medical degree from Johannes Gutenberg University in Mainz, Germany. He completed his urologic training at the University of Washington in Seattle and a Fellowship in Urologic Oncology at MD Anderson Cancer Center in Houston, Texas. He has a clinical subspecialty interest in bladder cancer. He maintains a grant-funded translational research program in urothelial carcinoma and is an active cancer clinical trialist in this field.
